Literature DB >> 16950884

COX-2 inhibitors in sports medicine: utility and controversy.

A Buvanendran, S S Reuben.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16950884      PMCID： PMC2465045          DOI： 10.1136/bjsm.2006.028944

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN： 0306-3674            Impact factor:   13.800


× No keyword cloud information.
  14 in total

1.  Immunology. Telling the brain about pain.

Authors:  T Bartfai
Journal:  Nature       Date:  2001-03-22       Impact factor: 49.962

2.  Cerebrospinal fluid and plasma pharmacokinetics of the cyclooxygenase 2 inhibitor rofecoxib in humans: single and multiple oral drug administration.

Authors:  Asokumar Buvanendran; Jeffrey S Kroin; Kenneth J Tuman; Timothy R Lubenow; Dalia Elmofty; Pauline Luk
Journal:  Anesth Analg       Date:  2005-05       Impact factor: 5.108

3.  Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.

Authors:  Scott D Solomon; John J V McMurray; Marc A Pfeffer; Janet Wittes; Robert Fowler; Peter Finn; William F Anderson; Ann Zauber; Ernest Hawk; Monica Bertagnolli
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

4.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

Authors:  Robert S Bresalier; Robert S Sandler; Hui Quan; James A Bolognese; Bettina Oxenius; Kevin Horgan; Christopher Lines; Robert Riddell; Dion Morton; Angel Lanas; Marvin A Konstam; John A Baron
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

5.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

Authors:  C Bombardier; L Laine; A Reicin; D Shapiro; R Burgos-Vargas; B Davis; R Day; M B Ferraz; C J Hawkey; M C Hochberg; T K Kvien; T J Schnitzer
Journal:  N Engl J Med       Date:  2000-11-23       Impact factor: 91.245

6.  The effect of cyclooxygenase-2 inhibition on analgesia and spinal fusion.

Authors:  Scott S Reuben; Evan F Ekman
Journal:  J Bone Joint Surg Am       Date:  2005-03       Impact factor: 5.284

Review 7.  Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets.

Authors:  Tarek A Samad; Adam Sapirstein; Clifford J Woolf
Journal:  Trends Mol Med       Date:  2002-08       Impact factor: 11.951

8.  Nonfatal sports- and recreation-related injuries treated in emergency departments--United States, July 2000-June 2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-08-23       Impact factor: 17.586

9.  Upregulation of spinal cyclooxygenase-2 in rats after surgical incision.

Authors:  Jeffrey S Kroin; Zao D Ling; Asokumar Buvanendran; Kenneth J Tuman
Journal:  Anesthesiology       Date:  2004-02       Impact factor: 7.892

10.  Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomized controlled trial.

Authors:  Asokumar Buvanendran; Jeffrey S Kroin; Kenneth J Tuman; Timothy R Lubenow; Dalia Elmofty; Mario Moric; Aaron G Rosenberg
Journal:  JAMA       Date:  2003-11-12       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.